Preclinical Development of Inhalable D-Cycloserine and Ethionamide to Overcome Pharmacokinetic Interaction and Enhance Efficacy Against Mycobacterium Tuberculosis

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00099-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Matrix Metalloproteinase Inhibitors Enhance the Efficacy of Frontline Drugs Against Mycobacterium Tuberculosis

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2018English

Effects of Ethionamide and Isoxyl on Mycolic Acid Synthesis in Mycobacterium Tuberculosis BCG

Journal of General Microbiology
1971English

Pentacyclic Nitrofurans With in Vivo Efficacy and Activity Against Nonreplicating Mycobacterium Tuberculosis

PLoS ONE
Multidisciplinary
2014English

Protective and Therapeutic Efficacy of Mycobacterium Smegmatis Expressing HBHA-hIL12 Fusion Protein Against Mycobacterium Tuberculosis in Mice

PLoS ONE
Multidisciplinary
2012English

D-Cycloserine to Enhance Extinction of Cue-Elicited Craving for Alcohol: A Translational Approach

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2015English

OsmC Proteins of Mycobacterium Tuberculosis and Mycobacterium Smegmatis Protect Against Organic Hydroperoxide Stress

Tuberculosis
Infectious DiseasesImmunologyMicrobiology
2011English

Interaction of Pattern Recognition Receptors With Mycobacterium Tuberculosis

Journal of Clinical Immunology
AllergyImmunology
2014English

Protective Efficacy of BCG Overexpressing an L,d-Transpeptidase Against M. Tuberculosis Infection

PLoS ONE
Multidisciplinary
2010English

In Vitro Activity of Tedizolid Against Mycobacterium Tuberculosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy